Natera Inc (NAS:NTRA)
$ 124.39 0.95 (0.77%) Market Cap: 15.38 Bil Enterprise Value: 14.82 Bil PE Ratio: 0 PB Ratio: 18.35 GF Score: 72/100

Natera Inc at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 08:00PM GMT
Release Date Price: $41.12 (+10.57%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Thank you for joining us. I'm here with Natera and I don't introduce anyone by name, but these 2 have really easy names where I can possibly not miss pronounce, Mike Brophy and Steve Chapman. The only company here today that I introduced by name.

Questions & Answers

David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

So let's just start with the thing everyone cares about Signatera. You're expecting 185,000 tests on the year. I had the highest numbers on the street, and I think you blew passed me. So really, what's working so well here. So sort of start with the softball.

Steven Leonard Chapman
Natera, Inc. - CEO, President & Director

Yes. Thanks. So yes, we were really impressed with the numbers as well. And I think when we kind of set 185,000 for the year, obviously, we're being conservative with kind of where we could finish up, but we're seeing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot